Clarification: Bristol-Myers-Cancer Drugs
TRENTON, N.J. — In a June 6 story about Bristol-Myers Squibb Co.'s research on cancer drugs, The Associated Press reported that the company's drug for advanced skin cancer was approved in the U.S. in March for use in patients who had failed on another therapy. The drug, Yervoy, also was approved for newly diagnosed patients.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.